Abstract
Introduction: Vasodilatation in response to NO is a fundamental response of the vasculature, and during aging, the vasculature is characterized by an increase in stiffness and decrease in sensitivity to NO mediated vasodilatation. Vascular tone is regulated by the activation of smooth muscle and nonmuscle (NM) myosin, which are regulated by the activities of myosin light chain kinase (MLCK) and MLC phosphatase. MLC phosphatase is a trimeric enzyme with a catalytic subunit, myosin targeting subunit (MYPT1) and 20 kDa subunit of unknown function. Alternative mRNA splicing produces LZ+/LZ- MYPT1 isoforms and the relative expression of LZ+/LZ- MYPT1 determines the sensitivity to NO mediated vasodilatation. This study tested the hypothesis that aging is associated with changes in LZ+ MYPT1 and NM myosin expression, which alter vascular reactivity.
Methods: We determined MYPT1 and NM myosin expression, force and the sensitivity of both endothelial dependent and endothelial independent relaxation in tertiary mesenteric arteries of young (6mo) and elderly (24mo) Fischer344 rats.
Results: The data demonstrate that aging is associated with a decrease in both the expression of NM myosin and force, but LZ+ MYPT expression and the sensitivity to both endothelial dependent and independent vasodilatation did not change. Further, smooth muscle cell hypertrophy increases the thickness of the medial layer of smooth muscle with aging.
Discussion: The reduction of NM myosin may represent an aging associated compensatory mechanism to normalize the stiffness of resistance vessels in response to the increase in media thickness observed during aging.
Introduction
Both cardiac and vascular dysfunction are associated with aging, and during aging, the vasculature is characterized by an increase in stiffness and decrease in sensitivity to NO mediated vasodilatation (; ; Shinmura et al., 2011; North and Sinclair, 2012). Endothelial dysfunction is thought to produce the decrease in sensitivity to NO mediated vasodilatation (Vatner et al., 2021). However, data are contradictory with some studies reporting that aging is associated endothelial dysfunction (; Lubomirov et al., 2021; Zhong et al., 2021) and other studies not finding aging-related endothelial dysfunction (; Luttrell et al., 2020). During aging, some have suggested that there is endothelial dysfunction in larger conduit arteries, but not smaller conduit or resistance vessels (Vatner et al., 2021). However, investigators have demonstrated a decrease in sensitivity to ACh mediated vasodilatation in both mouse mesenteric (Zhong et al., 2021) and femoral arteries (Lubomirov et al., 2021). Further, the response of vascular smooth muscle to contractile agonists in aging is variable with decreased (; Nicholson et al., 2022), increased (; Lubomirov et al., 2016; 2021) and unchanged (Zhong et al., 2021) sensitivity reported. The disparity is both vessel dependent (; Lubomirov et al., 2018; Luttrell et al., 2020; Valovič et al., 2023) and due to regional differences (distal vs. proximal) within the same vessel (Zhang et al., 2018).
The level of phosphorylation of the 20 kDa regulatory myosin light chain (MLC20) defines vascular tone (), and MLC20 phosphorylation is regulated by the activities of myosin light chain kinase (MLCK) and MLC phosphatase (; Somlyo and Somlyo, 2003; ). MLCK is regulated by Ca2+-calmodulin (), but the majority of signaling pathway that regulate vascular tone either inhibit or activate MLC phosphatase (Trinkle-Mulcahy et al., 1995; ; Somlyo and Somlyo, 2003; ). MLC phosphatase is a trimeric enzyme with a catalytic subunit, myosin targeting subunit (MYPT1) and 20 kDa subunit of unknown function (). Alternative mRNA splicing produces several MYPT1 isoforms (; Payne et al., 2004; Zhang and Fisher, 2007; Shukla and Fisher, 2008) and exclusion/inclusion of exon24 has been demonstrated to produce LZ+/LZ- MYPT1 isoforms (Payne et al., 2004; Shukla and Fisher, 2008; Zheng et al., 2015; Reho et al., 2016).
NO mediated vasodilatation is a fundamental response of the vasculature (), and protein kinase G (PKG) mediated activation of MLC phosphatase is dependent on the interaction of PKG with the LZ+ MYPT isoform (Surks et al., 1999; Surks and Mendelsohn, 2003; ). The expression of a LZ+ MYPT1 isoform has been demonstrated to be necessary for NO/cGMP/PKG mediated activation of the MLC phosphatase (; Yuen et al., 2014), and the sensitivity to NO mediated vasodilatation has been demonstrated to be defined by the relative expression of LZ+/LZ- MYPT1 (; ; Payne et al., 2006; Yuen et al., 2011; Reho et al., 2016). Further, in addition to smooth muscle (SM) myosin, nonmuscle (NM) myosin is expressed in smooth muscle and has been demonstrated to participate in smooth muscle contraction (Morano et al., 2000; ; Rhee et al., 2006; Yuen et al., 2009; Zhang and Gunst, 2017; Lubomirov et al., 2023); changes in NM myosin expression and NM myosin activation have been demonstrated to influence vascular tone (Morano et al., 2000; ; Rhee et al., 2006; Yuen et al., 2009; Lubomirov et al., 2023).
This study was designed to test the hypothesis that aging is associated with changes in LZ+ MYPT1 and NM myosin expression, which then alter vascular reactivity. MYPT1 and NM myosin expression was determined in both tertiary mesenteric arteries and the aorta of young (6mo) and elderly (24mo) Fischer344 rats. In addition, in tertiary mesenteric vessels, we assessed vascular reactivity by determining maximal force and the sensitivity of both endothelial dependent and endothelial independent relaxation.
Methods
Animals
The experimental protocol was approved by the Mayo Clinic Institutional Animal Care and Use Committee and conformed to the guidelines of the National Institutes of Health. Male Fischer344 rats were studied at 6mo and 24mo.
Immunoblotting
As previously described (; Yuen et al., 2009; ; ), immunoblotting was used to define protein expression. Briefly, samples of aortic and tertiary mesenteric vessels were homogenized in SDS sample buffer and total protein extract was resolved by SDS-PAGE, with sample loading normalized to total protein calculated within each band calculated from the stain-free prescast gel (Biorad, Cat#64551870), as previously described (Schaible et al., 2016; Yap et al., 2020; ). After SDS-PAGE, proteins were transferred onto an immunoblot membrane (Biorad Cat#1629177) and anti-MYPT1 (ab32519, Abcam), -LZ+ MYPT1 (), -smooth muscle myosin heavy chain (ab53219, Abcam) and -α smooth muscle actin (ab5694, Abcam) were used to visualize the proteins. The resulting immunoblots were scanned and analyzed using ImageLab software (), and protein expression was normalized for total protein (TP) as previously described (Schaible et al., 2016; Yap et al., 2020; ).
Two-dimensional PAGE
NM and SM myosin expression was determined using 2D SDS-PAGE as previously described (Yuen et al., 2009; ; ). We have demonstrated that this technique resolves the nonphosphorylated and phosphorylated SM myosin light chain (SM LC) and NM myosin light chain (NM LC) as four distinct spots (Yuen et al., 2009; ; ). Briefly, samples of aortic and tertiary mesenteric smooth muscle were manually homogenized in 2D gel extraction buffer (7M urea, 2M thiourea, 4% CHAPS, 1% 3–5.6 immobilized pH gradient (IPG) buffer and EDTA-free Protease Inhibitor and PhosStop Phosphatase Inhibitor (Roche, Indianapolis, Ind., USA). The homogenates were cleared of lipids and extraneous salts using the 2D gel clean up kit (GE Healthcare). The acidic halves of 13-cm IPG DryStrip gels (pH 3–5.6 NL) were rehydrated in the presence of suitable amounts of sample in rehydration buffer solution (7M urea, 2M thiourea, 2% CHAPS, 0.5% pH 3.5–5 IPG buffer, 0.002% bromophenol blue and 12 μM/ml Destreak Reagent) for at least 10 h in the ‘face-down’ mode on the Ettan IPG rehydration tray and then resolved by isoelectric focusing in the ‘face-up’ mode on an Ettan IPGphor III (GE Healthcare). Following isoelectric focusing, the gel strips were equilibrated in 6M urea, 50 mM Tris-HCl, pH 6.4, 30% glycerol, 2% (w/v) SDS and 0.002% bromophenol blue, first containing 130 mM DTT for 15 min and then containing 135 mM iodoacetamide for 15 min before undergoing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for protein separation by molecular weight using the Bis-Tris buffering system with 12% gels (29:1). Subsequently, resolved 2D SDS-PAGE gels were silver stained. Gels were scanned using a high-resolution digital scanner (EPSON Perfection V750 Pro), and the spots were quantified using ImageQuant TL software. The two spots closest to the anode (spots 1 & 2) represent the phosphorylated and nonphosphorylated NM LC and the two spots nearest the cathode (spots 3 & 4) represent the phosphorylated and nonphosphorylated SM LC. As previously described (Yuen et al., 2009), the expression of NM myosin is calculated as [(1 + 2)/(1 + 2+3 + 4)]x100%].
Muscle mechanics in tertiary mesenteric arteries
Mechanical studies were conducted using protocols previously published protocols (). Briefly, for force recordings, isolated tertiary mesenteric preparations (100–200 μm in diameter; ∼2 mm in length) with an intact endothelium were mounted using wires (40 μm in diameter) on a DMT 4-channel myograph system (Mulvany and Halpern, 1977; 2018; Mulvany et al., 1982) and stretched to Lo (the length for maximal force) in the myograph chamber containing continuously oxygenated physiological saline solution (PSS in mM: 140 NaCl, 3.7 KCl, 2.5 CaCl2, 0.81 MgSO4, 1.19 KH2PO4, 0.03 EDTA, 5.5 Glucose, 25 HEPES, pH 7.4). Following stretching the preparation to Lo, the vessels were allowed to equilibrate for 1 h, and then were stimulated to contract with 80 mM KCl depolarization (in mM: 64.5 NaCl, 80 KCl, 2.5 CaCl2, 0.81 MgSO4, 1.19 KH2PO4, 0.03 EDTA, 5.5 Glucose, 25 HEPES, pH 7.4). The initial response to KCl depolarization was maintained for 10–15 min, before the vessel was relaxed with PSS. Then, the vessels were depolarized with KCl and after the force reached a steady state, the dose-response relationship of force relaxation produced by acetylcholine (ACh; 10nM-10 μM) was determined. The preparation was transferred to PSS, and following another contraction with 80 mM KCl, the relaxation produced by the cell permeable cGMP analog, 8Br-cGMP (100 μM), was assessed. Mesenteric preparations isolated from the same animal were used for both mechanical and molecular studies.
Quantification of vessel hypertrophy
The extent of vascular smooth muscle cell hypertrophy was determined from hematoxylin-eosin (HE) stained sections of tertiary mesenteric arteries as previously described (). The vessels were embedded in paraffin and then thin sections (10 μm) were stained with H&E (). Photomicrographs were obtained, and for each slide, at least six fields per slide were analyzed. Quantification of the total smooth muscle cell number, the thickness of the media layer of smooth muscle cells as well as vessel diameter and cross-sectional area was performed using ImageJ analysis software (Version 1.49, NIH, Bethesda, MD).
Statistical analysis
All data are presented as mean ± SEM (n = number of animals). In designing experiments, a power analysis was performed (power = 80%, α = 0.05) to determine the number of animals per group (6 animals per group). Differences between groups (6mo vs. 24mo) were compared using a two-way ANOVA, and if significant differences were found, a Student’s t-test was used post hoc to compare values with a p < 0.05 level significance.
Results
The expression of MYPT1 and LZ+ MYPT1 did not change with aging (6mo (n = 6) vs. 24mo (n = 6)). in either the aorta (Figure 1) or tertiary mesenteric arteries (Figure 1). In the aorta, MYPT1 expression normalized to total protein (MYPT1/TP) was 22.6 ± 2.2au vs. 18.5 ± 0.9au (p > 0.05) and LZ+ MYPT1/TP expression was 15.7 ± 3.4au vs. 11.1 ± 1.2au (p > 0.05). In the tertiary mesentery arteries, MYPT1/TP expression was 2.8 ± 0.3au vs. 3.5 ± 0.3au (p > 0.05), while MYPT1 LZ+/TP was 13.8 ± 1.9au vs. 14.1 ± 5.0au (p > 0.05).
FIGURE 1
The expression of NM and SM myosin was assessed using 2-dimensional PAGE (Yuen et al., 2009; ; ; ). During aging in the aorta (Figure 2), NM myosin expression was similar at 6mo (31% ± 2%, n = 6) and 24mo (26% ± 4%, n = 6). However, in the mesenteric artery, the expression of NM myosin significantly decreased with aging. Relative to total myosin expression, NM myosin expression was 22% ± 3% vs. 12% ± 2% (6mo v 24mo, p = 0.025).
FIGURE 2
The mechanical properties of tertiary mesenteric arteries were defined by the maximal force in response to 80 mM KCl and the sensitivity of endothelial dependent (ACh) and endothelial independent (8Br-cGMP) relaxation. Force for KCl depolarization was greater at 6mo (n = 6) than 24mo (n = 6); 35 ± 13 mN/mm2 vs. 8 ± 4 mN/mm2 (Figure 3, p = 0.016). Endothelial dependent relaxation was assessed by determining the sensitivity to ACh mediated relaxation; the sensitivity of relaxation to ACh in tertiary mesenteric arteries was similar in vessels isolated from 6mo to 24mo old rats (Figure 3). We also defined endothelial independent relaxation using 8Br-cGMP; 100 μM 8Br-cGMP mediated relaxation was no different in tertiary mesenteric arteries from young and old rats (46% ± 7% vs. 43% ± 5%, p > 0.05, Figure 3).
FIGURE 3
The final series of experiments measured the thickness of the medial smooth muscle layer from stained sections of tertiary mesenteric arteries (Figure 4). Comparing 6mo (n = 4) and 24mo (n = 4), neither lumen diameter (62 ± 8 μm vs. 76 ± 8 μm, p > 0.05) nor lumen cross-sectional area (190 ± 20 μm2 vs. 240 ± 20 μm2, p > 0.05) changed. In contrast, the thickness of the medial layer of smooth muscle increased with aging from 36 ± 3 μm at 6mo to 51 ± 5 μm at 24mo (p = 0.022, Figure 4). The number of smooth muscle cells in the medial layer of the cross-section was similar (p > 0.05); 16 ± 2 (6mo) vs. 17 ± 1 (24mo). Additionally, the expression of both the smooth muscle myosin heavy chain normalized to total protein (SM MyHC/TP) at 6mo (14 ± 1au, n = 6) and 24mo (16 ± 1au, n = 6) and α-smooth muscle actin (α-SM actin/TP) at 6mo (38 ± 2au, n = 6) and 24mo (37 ± 2au, n = 6) was similar (Figure 5, p > 0.05).
FIGURE 4
FIGURE 5
Discussion
The results of the present study demonstrate that proteins regulating vascular reactivity are modulated during aging in a resistance vessel (tertiary mesenteric vessel), but not in a conduit vessel (aorta). Vascular tone is regulated by the extent of phosphorylation of MLC20 (), which is controlled by the activities of MLCK and MLC phosphatase (; Somlyo and Somlyo, 2003; ). MLCK is regulated by Ca2+-calmodulin (). However, the majority of signaling pathways that regulate vascular tone converge on MLC phosphatase (; Somlyo and Somlyo, 2003; ). Inhibition of MLC phosphatase (Trinkle-Mulcahy et al., 1995) by Rho kinase (; ; Swärd et al., 2000; Seko et al., 2003), Zip kinase (MacDonald et al., 2001), ILK (; ; Murányi et al., 2002; Wilson et al., 2005), CPI-17 (; ; Woodsome et al., 2006), PHI-1 (; ; ) and PKC (; Walsh et al., 1996) increases MLC20 phosphorylation and vascular tone, while PKG activates MLC phosphatase (; ), which decreases MLC20 phosphorylation and vascular tone. Nitric oxide mediated vasodilatation is a fundamental property of the vasculature (), and the sensitivity of NO mediated smooth muscle relaxation has been demonstrated to be dependent on the interaction of PKG with LZ+ MYPT1 (Surks et al., 1999; ; Sharma et al., 2008). Further, PKG phosphorylates only LZ+ MYPT1 isoforms at S667 (Yuen et al., 2011; 2014), which increases MLC phosphatase activity (Yuen et al., 2014), and consequently, PKG only activates MLC phosphatase expressing a LZ+ MYPT1. Thus, the sensitivity of NO mediated smooth muscle relaxation is dependent on the relative expression of LZ+/LZ- MYPT1 isoforms (; ; Reho et al., 2016). Our data demonstrate that neither MYPT1 nor LZ+ MYPT1 expression changes during aging in either a conduit or a resistance vessel (Figure 1). These results would predict that the sensitivity to both endothelial dependent and endothelial independent vasodilatation would be similar in young and old animals, which is consistent with our results demonstrating that the sensitivity of relaxation to both ACh and 8Br-cGMP is similar in mesenteric vessel of young and old animals (Figure 3). However, a limitation of this study is the use of a single concentration of 8Br-cGMP, which produced similar relaxation of mesenteric vessels from young and old animals (Figure 3), and more concentrations are necessary to completely demonstrate similar sensitivity to 8Br-cGMP. However, our data show no difference in sensitivity to ACh (Figure 3), which would suggest that the sensitivity of 8Br-cGMP should also be similar in tertiary mesenteric arteries of young and old animals.
Endothelial dysfunction is thought to underlie an age-related decrease in NO mediated vasodilatation (Vatner et al., 2021), but there are differences in endothelial function in different vessels as well as location within the same vessel (Vatner et al., 2021). Investigators have demonstrated that the sensitivity of relaxation induced by ACh (endothelial dependent) and nitroprusside (endothelial independent) is impaired in rat abdominal aorta, but not the femoral artery, iliac artery or gastrocnemius muscle artery (Luttrell et al., 2020). However, Barton et al. () demonstrated that in rats there was an age-related decrease in sensitivity to endothelial dependent, but not endothelial independent relaxation in the aorta, but the response to ACh and nitroprusside was similar in the femoral artery isolated from young and old animals. In mesenteric resistance vessels of elderly mice, compared to young mice, Zhong et al. (Zhong et al., 2021) demonstrated that during aging maximal force and sensitivity to ACh mediated relaxation were reduced, but there was no difference in the sensitivity to nitroprusside. On the other hand, in young mice, Lubomirov et al. (Lubomirov et al., 2018) showed that due to the higher LZ + MYPT1 expression, the basilar artery was more sensitive to both endothelial dependent and endothelial independent relaxation than the femoral artery. Further, the femoral artery isolated from elderly mice, compared to young mice, had a decrease in sensitivity of contraction to thromboxane, and an aging-related decrease in LZ+ MYPT1 expression produced a decrease in sensitivity to ACh (Lubomirov et al., 2021). The relative expression of LZ+/LZ-MYPT1 has been documented to be developmentally regulated (; Payne et al., 2006), tissue specific (; ; Payne et al., 2004; 2006) and modulated in disease (; ; Lu et al., 2008; ; ; ; Reho and Fisher, 2015; Lyle et al., 2020; ). The disparities between our results and those reported by others (; Lubomirov et al., 2016; 2018; 2021; Luttrell et al., 2020; Zhong et al., 2021) could be due to differences in species (rat vs. mouse), strain of animal and/or vessel studied. In addition, MYPT1 has multiple phosphorylation sites which regulate MLC phosphatase activity (Somlyo and Somlyo, 1994; ; ), and in murine basilar arteries, others have demonstrated that MYPT1 phosphorylation at T853 increases during aging (Lubomirov et al., 2023). We did not measure MYPT1 phosphorylation, and changes in MYPT1 phosphorylation could contribute to the disparities among studies. However, our results demonstrate that LZ+ MYPT1 expression does not change with aging (Figure 1). Since the sensitivity to NO mediated vasodilatation is defined by LZ+/LZ- MYPT1 expression (Surks et al., 1999; ; Yuen et al., 2011; 2014; Reho et al., 2016), there should be no change in sensitivity to either endothelial dependent or independent smooth muscle relaxation, which agrees with our results (Figure 3). Thus, similar to Lubomirov (Lubomirov et al., 2016; 2018; 2021), our results are consistent with the sensitivity of a vessel to NO being defined by LZ+/LZ- MYPT1 expression; changes in LZ + MYPT1 expression regulate the sensitivity of the vasculature to NO/cGMP/PKG-mediated relaxation (; ; Yuen et al., 2011; 2014; Reho et al., 2016).
In tertiary mesenteric vessels, our data demonstrate that NM myosin expression is significantly lower in elderly compared to young rats (Figure 2). In contrast, in the aorta, NM myosin expression did not change during aging (Figure 2). Similar to SM myosin, NM myosin is regulated by phosphorylation of its light chain (). Further, NM myosin phosphorylation is regulated during contraction of smooth muscle (Yuen et al., 2009; Zhang and Gunst, 2017) and NM myosin has been demonstrated to participate in force maintenance (Morano et al., 2000; ; Rhee et al., 2006; Yuen et al., 2009; Zhang and Gunst, 2017; Lubomirov et al., 2023); both a change in NM myosin expression (Morano et al., 2000; ; Yuen et al., 2009) and inhibition of the NM myosin AMATPase (Rhee and Brozovich, 2003; Lubomirov et al., 2023) have been demonstrated to produce a reduction in force, which demonstrate that changes in NM myosin expression will alter force. In tertiary mesenteric vessels, during aging, our data show NM myosin expression is reduced by ∼10% (Figure 2), while there is no change in NM myosin expression in the aorta, a large conduit vessel. The aging associated decrease in NM myosin expression in tertiary mesenteric vessel would be expected to reduce force (Morano et al., 2000; ; Rhee et al., 2006; Yuen et al., 2009; Zhang and Gunst, 2017), which is consistent with our results (Figure 3). The mechanism that produces the decrease in NM myosin expression in the tertiary mesenteric vessels with aging is unknown but could be a compensatory mechanism to normalize blood pressure in response to the increase in vascular stiffness documented to occur during aging (Qiu et al., 2010; Vatner et al., 2021).
Aging of the vasculature is associated with an increase in vessel stiffness (Moreau et al., 1998; ; Vatner et al., 2021) and histological changes; the ratio of collagen to elastin increases with age (Zhang et al., 2018; ; Vatner et al., 2021). Additionally, the ratio of collagen to elastin is higher in the abdominal than the thoracic aorta (Zhang et al., 2018; Vatner et al., 2021), and the increase in collagen/elastin in the vessel contributes to the age-related increase in vessel stiffness (Zhang et al., 2018; ; Vatner et al., 2021). Peripheral arteries are less elastic and more muscular, and thus are stiffer than central arteries (Yu and McEniery, 2020), and with aging, the increase in stiffness in peripheral arteries is less pronounced than in the aorta (Yu and McEniery, 2020). In tertiary mesenteric vessels, our data demonstrate neither lumen diameter nor cross-sectional area change during aging. However, the medial layer of smooth muscle of the vessel is significantly thicker in elderly animals (Figure 4), while the cell number is similar (16 ± 2 vs. 17 ± 1, p > 0.05) suggesting that smooth muscle cell hypertrophy produces the increase in medial thickness. These data agree with those reported by other investigators that have shown that during aging of rat basilar and mesenteric small arteries, medial thickness increases (Moreau et al., 1998; ). However, in mesenteric vessels of mice, others have reported that medial thickness does not change during aging (Zhong et al., 2021). During aging, our data show an increase in the thickness of the media (Figure 4), which would be expected to increase force and vessel stiffness. However, force was lower for KCl stimulated contractions in mesenteric vessels from elderly compared to young rats (Figure 3). The data also demonstrate that SM MyHC and α-SM actin expression does not change with aging (Figure 5), suggesting that the smooth muscle phenotype does not change from contractile to synthetic during aging (Rensen et al., 2007). However, NM myosin has been shown to participate in smooth muscle contraction (Morano et al., 2000; ; Yuen et al., 2009), and both decreasing NM myosin expression (Yuen et al., 2009) and inhibiting of NM myosin (Rhee et al., 2006; Lubomirov et al., 2023) reduce force. Our data demonstrating a decrease in NM myosin expression in mesenteric arteries (Figure 2) would decrease contractile force, which is consistent with our results (Figure 3).
In summary, our results demonstrate differences in age-related alterations in both the expression of contractile and regulatory proteins in a resistance vs. a conduit vessel, which is consistent with the results of others and demonstrates aging related changes are vessel dependent (; Lubomirov et al., 2018; Luttrell et al., 2020; Vatner et al., 2021). There are no changes in LZ+ MYPT1 or NM myosin in a conduit vessel. In a resistance vessel, our data demonstrate there is no age-related changes in MYPT1 LZ+ expression and consequently, there is no change in the sensitivity to either endothelial dependent (ACh) or endothelial independent (8Br-cGMP) mediated vasodilatation. However, in a resistance vessel, although the thickness of the medial layer of smooth muscle increases with aging, most likely due to hypertrophy of the smooth muscle cells, NM myosin expression is significantly depressed. The decrease in NM myosin expression participates in the mechanism for the aging-related reduction in force in response to KCl depolarization, and the reduction of NM myosin may represent an aging associated compensatory mechanism to mitigate the increase in stiffness of resistance vessels in response to the increase in media thickness and stiffness observed during aging.
Statements
Data availability statement
The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.
Ethics statement
The animal study was approved by the Mayo Clinic Institutional Animal Care and Use Committee. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
YH: Data curation, Formal Analysis, Investigation, Methodology, Resources, Writing–original draft. RB: Data curation, Investigation, Writing–review and editing. MF: Data curation, Formal Analysis, Investigation, Methodology, Writing–review and editing. GS: Supervision, Writing–review and editing, Methodology. FB: Conceptualization, Formal Analysis, Funding acquisition, Supervision, Writing–review and editing, Methodology.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by a Mayo Clinic CV Prospective Research Award (FVB).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AlbuM.ŞeicaruD. A.PleşeaR. M.MireaO. C.GherghiceanuF.GrigoreanV. T.et al (2021). Assessment of the aortic wall histological changes with ageing. Romanian J Morphol Embryology Revue Roumaine De Morphol Embryologie62, 85–100. 10.47162/rjme.62.1.08
2
AraratE.BrozovichF. V. (2009). Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression. PLoS ONE4, e5144. 10.1371/journal.pone.0005144
3
BarrosP. R.CostaT. J.AkamineE. H.TostesR. C. (2021). Vascular aging in rodent models: contrasting mechanisms driving the female and male vascular senescence. Front. Aging2, 727604. 10.3389/fragi.2021.727604
4
BarsottiR. J.IkebeM.HartshorneD. J. (1987). Effects of Ca2+, Mg2+, and myosin phosphorylation on skinned smooth muscle fibers. Am. J. Physiol-cell P. H.252, C543–C554. 10.1152/ajpcell.1987.252.5.c543
5
BartonM.CosentinoF.BrandesR. P.MoreauP.ShawS.LüscherT. F. (1997). Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertens. (Dallas, Tex 1979)30, 817–824. 10.1161/01.hyp.30.4.817
6
BrozovichF. V.NicholsonC. J.DegenC. V.GaoY. Z.AggarwalM.MorganK. G. (2016). Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharmacol. Rev.68, 476–532. 10.1124/pr.115.010652
7
ChenF. C.OgutO.RheeA. Y.HoitB. D.BrozovichF. V. (2006). Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation. J. Mol. Cell Cardiol.41, 488–495. 10.1016/j.yjmcc.2006.05.018
8
CremoC. R.WangF.FacemyerK.SellersJ. R. (2001). Phosphorylation-dependent regulation is absent in a nonmuscle heavy meromyosin construct with one complete head and one head lacking the motor domain. J. Biol. Chem.276, 41465–41472. 10.1074/jbc.m107103200
9
DegenC. V.BishuK.ZakeriR.OgutO.RedfieldM. M.BrozovichF. V. (2015). The emperor’s New clothes: PDE5 and the heart. Plos One10, e0118664. 10.1371/journal.pone.0118664
10
DengJ. T.LieropJ. E. V.SutherlandC.WalshM. P. (2001). Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase. J. Biol. Chem.276, 16365–16373. 10.1074/jbc.m011634200
11
DengJ. T.SutherlandC.BrautiganD. L.EtoM.WalshM. P. (2002). Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem. J.367, 517–524. 10.1042/bj20020522
12
DirksenW. P.VladicF.FisherS. A. (2000). A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch. Am. J. Physiol-cell P. H.278, C589–C600. 10.1152/ajpcell.2000.278.3.c589
13
El-TouhkyA.GivenA. M.CochardA.BrozovichF. V. (2005). PHI-1 induced enhancement of myosin phosphorylation in chicken smooth muscle. FEBS Lett.579, 4271–4277. 10.1016/j.febslet.2005.06.059
14
El-ToukhyA.GivenA. M.OgutO.BrozovichF. V. (2006). PHI-1 interacts with the catalytic subunit of myosin light chain phosphatase to produce a Ca(2+) independent increase in MLC(20) phosphorylation and force in avian smooth muscle. FEBS Lett.580, 5779–5784. 10.1016/j.febslet.2006.09.035
15
EtoM. (2009). Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J. Biol. Chem.284, 35273–35277. 10.1074/jbc.r109.059972
16
EtoM.KarginovA.BrautiganD. L. (1999). A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes. Biochemistry38, 16952–16957. 10.1021/bi992030o
17
EtoM.OhmoriT.SuzukiM.FuruyaK.MoritaF. (1995). A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J. Biochem.118, 1104–1107. 10.1093/oxfordjournals.jbchem.a124993
18
FurchgottR. F. (1999) Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Berlin, Germany: Springer.
19
FurchgottR. F.ZawadzkiJ. V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature288, 373–376. 10.1038/288373a0
20
GivenA. M.OgutO.BrozovichF. V. (2007). MYPT1 mutants demonstrate the importance of aa 888-928 for the interaction with PKGIalpha. Am. J. Physiology- Cell Physiology292, C432–C439. 10.1152/ajpcell.00175.2006
21
HanY. S.ArteagaG. M.SharainK.SieckG. C.BrozovichF. V. (2021). Rat model of heart failure with preserved ejection fraction: changes in contractile proteins regulating Ca 2+ cycling and vascular reactivity. Circulation144, 1355–1358. 10.1161/circulationaha.121.054465
22
HanY. S.BrozovichF. V. (2013). Altered reactivity of tertiary mesenteric arteries following acute myocardial ischemia. J. Vasc. Res.50, 100–108. 10.1159/000343015
23
HartshorneD. J.ItoM.ErdodiF. (1998). Myosin light chain phosphatase: subunit composition, interactions and regulation. J. muscle Res. Cell Motil.19, 325–341. 10.1023/a:1005385302064
24
HorowitzA.Clement-ChomienneO.WalshM. P.MorganK. G. (1996). Epsilon-isoenzyme of protein kinase C induces a Ca(2+)-independent contraction in vascular smooth muscle. Am. J. Physiol.-Cell Physiol.271, C589–C594. 10.1152/ajpcell.1996.271.2.c589
25
HuangQ. Q.FisherS. A.BrozovichF. V. (2004). Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation. J. Biol. Chem.279, 597–603. 10.1074/jbc.m308496200
26
IkebeM.HartshorneD. J. (1985). Effects of Ca2+ on the conformation and enzymatic activity of smooth muscle myosin. J. Biol. Chem.260, 13146–13153. 10.1016/s0021-9258(17)38850-6
27
KarimS. M.RheeA. Y.GivenA. M.FaulxM. D.HoitB. D.BrozovichF. V. (2004). Vascular reactivity in heart failure: role of myosin light chain phosphatase. Circ. Res.95, 612–618. 10.1161/01.res.0000142736.39359.58
28
KhatriJ. J.JoyceK. M.BrozovichF. V.FisherS. A. (2001). Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J. Biol. Chem.276, 37250–37257. 10.1074/jbc.m105275200
29
KitazawaT.GaylinnB. D.DenneyG. H.SomlyoA. P. (1991a). G-protein-mediated Ca2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation. J. Biol. Chem.266, 1708–1715. 10.1016/s0021-9258(18)52353-x
30
KitazawaT.MasuoM.SomlyoA. P. (1991b). G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc. Natl. Acad. Sci.88, 9307–9310. 10.1073/pnas.88.20.9307
31
KonikE. A.HanY. S.BrozovichF. V. (2013). The role of pulmonary vascular contractile protein expression in pulmonary arterial hypertension. J. Mol. Cell Cardiol.65, 147–155. 10.1016/j.yjmcc.2013.10.009
32
LakattaE. G. (1990). Changes in cardiovascular function with aging. Eur. Heart J.11, 22–29. 10.1093/eurheartj/11.suppl_c.22
33
LakattaE. G. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation107, 490–497. 10.1161/01.cir.0000048894.99865.02
34
LinY.-Y.HongY.ZhouM.-C.HuangH.-L.ShyuW.-C.ChenJ.-S.et al (2020). Exercise training attenuates cardiac inflammation and fibrosis in hypertensive ovariectomized rats. J. Appl. Physiol. (Bethesda, Md 1985)128, 1033–1043. 10.1152/japplphysiol.00844.2019
35
LincolnT. M. (1989). Cyclic GMP and mechanisms of vasodilation. Pharmacol. Ther.41, 479–502. 10.1016/0163-7258(89)90127-7
36
LöfgrenM.EkbladE.MoranoI.ArnerA. (2003). Nonmuscle Myosin motor of smooth muscle. J. General Physiology121, 301–310. 10.1085/jgp.200208720
37
LooB. van derKoppensteinerR.LüscherT. F. (2004). Wie altern Gefäße? Mechanismen und klinische Implikationen. Vasa33, 3–11. 10.1024/0301-1526.33.1.3
38
LuY.ZhangH.GokinaN.MandalaM.SatoO.IkebeM.et al (2008). Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy. Am. J. Physiology- Cell Physiology294, C564–C571. 10.1152/ajpcell.00285.2007
39
LubomirovL. T.JänschM. H.PapadopoulosS.SchroeterM. M.MetzlerD.BustM.et al (2021). Senescent murine femoral arteries undergo vascular remodelling associated with accelerated stress-induced contractility and reactivity to nitric oxide. Basic Clin. Pharmacol.130, 70–83. 10.1111/bcpt.13675
40
LubomirovL. T.PapadopoulosS.FilipovaD.BaransiS.TodorovićD.LakeP.et al (2018). The involvement of phosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) and MYPT1 isoform expression in NO/cGMP mediated differential vasoregulation of cerebral arteries compared to systemic arteries. Acta Physiol.224, e13079. 10.1111/apha.13079
41
LubomirovL. T.PapadopoulosS.PützS.WelterJ.KlöckenerT.WeckmüllerK.et al (2016). Aging-related alterations in eNOS and nNOS responsiveness and smooth muscle reactivity of murine basilar arteries are modulated by apocynin and phosphorylation of myosin phosphatase targeting subunit-1. J. Cereb. Blood Flow. Metab.37, 1014–1029. 10.1177/0271678x16649402
42
LubomirovL. T.SchroeterM. M.HasseV.FrohnM.MetzlerD.BustM.et al (2023). Dual thick and thin filament linked regulation of stretch- and L-NAME-induced tone in young and senescent murine basilar artery. Front. Physiol.14, 1099278. 10.3389/fphys.2023.1099278
43
LuttrellM.KimH.ShinS. Y.HollyD.MassettM. P.WoodmanC. R. (2020). Heterogeneous effect of aging on vasorelaxation responses in large and small arteries. Physiol. Rep.8, e14341. 10.14814/phy2.14341
44
LyleM. A.AlabdaljabarM. S.HanY. S.BrozovichF. V. (2020). The vasculature in HFpEF vs HFrEF: differences in contractile protein expression produce distinct phenotypes. Heliyon6, e03129. 10.1016/j.heliyon.2019.e03129
45
MacDonaldJ. A.BormanM. A.MuranyiA.SomlyoA. V.HartshorneD. J.HaysteadT. A. (2001). Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc. Natl. Acad. Sci. U. S. A.98, 2419–2424. 10.1073/pnas.041331498
46
MoranoI.ChaiG. X.BaltasL. G.Lamounier-ZepterV.LutschG.KottM.et al (2000). Smooth-muscle contraction without smooth-muscle myosin. Nat. Cell Biol.2, 371–375. 10.1038/35014065
47
MoreauP.d’UscioL. V.LüscherT. F. (1998). Structure and reactivity of small arteries in aging. Cardiovasc. Res.37, 247–253. 10.1016/s0008-6363(97)00225-3
48
MulvanyM. J.HalpernW. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res.41, 19–26. 10.1161/01.res.41.1.19
49
MulvanyM. J.HalpernW. (2018). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res.41, 19–26. 10.1161/01.res.41.1.19
50
MulvanyM. J.NilssonH.FlatmanJ. A.KorsgaardN. (1982). Potentiating and depressive effects of ouabain and potassium-free solutions on rat mesenteric resistance vessels. Circ. Res.51, 514–524. 10.1161/01.res.51.4.514
51
MurányiA.MacDonaldJ. A.DengJ. T.WilsonD. P.HaysteadT. A. J.WalshM. P.et al (2002). Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem. J.366, 211–216. 10.1042/bj20020401
52
NicholsonC. J.XingY.LeeS.LiangS.MohanS.O’RourkeC.et al (2022). Ageing causes an aortic contractile dysfunction phenotype by targeting the expression of members of the extracellular signal‐regulated kinase pathway. J. Cell Mol. Med.26, 1456–1465. 10.1111/jcmm.17118
53
NorthB. J.SinclairD. A. (2012). The intersection between aging and cardiovascular disease. Circ. Res.110, 1097–1108. 10.1161/circresaha.111.246876
54
PayneM. C.ZhangH.-Y.ProsdocimoT.JoyceK. M.KogaY.IkebeM.et al (2006). Myosin phosphatase isoform switching in vascular smooth muscle development. J. Mol. Cell. Cardiol.40, 274–282. 10.1016/j.yjmcc.2005.07.009
55
PayneM. C.ZhangH.-Y.ShirasawaY.KogaY.IkebeM.BenoitJ. N.et al (2004). Dynamic changes in expression of myosin phosphatase in a model of portal hypertension. Am. J. physiology Heart circulatory physiology286, H1801–H1810. 10.1152/ajpheart.00696.2003
56
QiuH.ZhuY.SunZ.TrzeciakowskiJ. P.GansnerM.DepreC.et al (2010). Short communication: vascular smooth muscle cell stiffness as a mechanism for increased aortic stiffness with aging. Circ. Res.107, 615–619. 10.1161/circresaha.110.221846
57
RehoJ. J.FisherS. A. (2015). The stress of maternal separation causes misprogramming in the postnatal maturation of rat resistance arteries. AJP Heart Circulatory Physiology309, H1468–H1478. 10.1152/ajpheart.00567.2015
58
RehoJ. J.KenchegowdaD.AsicoL. D.FisherS. A. (2016). A splice variant of the myosin phosphatase regulatory subunit tunes arterial reactivity and suppresses response to salt loading. AJP Heart Circulatory Physiology310, H1715–H1724. 10.1152/ajpheart.00869.2015
59
RensenS. S. M.DoevendansP. A. F. M.EysG. J. J. M. van (2007). Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Hear. J.15, 100–108. 10.1007/bf03085963
60
RheeA. Y.BrozovichF. V. (2003). Force maintenance in smooth muscle: analysis using sinusoidal perturbations. Arch. Biochem. Biophys.410, 25–38. 10.1016/s0003-9861(02)00634-3
61
RheeA. Y.OgutO.BrozovichF. V. (2006). Nonmuscle myosin, force maintenance, and the tonic contractile phenotype in smooth muscle. Pflügers Archiv - Eur. J. Physiology452, 766–774. 10.1007/s00424-006-0091-4
62
SchaibleN.HanY. S.HoangT.ArteagaG.TveitaT.SieckG. (2016). Hypothermia/rewarming disrupts excitation-contraction coupling in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol.310, H1533–H1540. 10.1152/ajpheart.00840.2015
63
SekoT.ItoM.KureishiY.OkamotoR.MorikiN.OnishiK.et al (2003). Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circulation Res.92, 411–418. 10.1161/01.res.0000059987.90200.44
64
SharmaA.ZhouG.KupfermanJ.SurksH.ChristensenE.ChouJ.et al (2008). Probing the interaction between the coiled-coil leucine zipper of cGMP-dependent protein kinase Ialpha and the C-terminus of the myosin binding subunit of the myosin light chain phosphatase. J. Biol. Chem.283, 32860–32869. 10.1074/jbc.m804916200
65
ShinmuraK.TamakiK.SanoM.MurataM.YamakawaH.IshidaH.et al (2011). Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J. Mol. Cell Cardiol.50, 117–127. 10.1016/j.yjmcc.2010.10.018
66
ShuklaS.FisherS. A. (2008). Tra2beta as a novel mediator of vascular smooth muscle diversification. Circ. Res.103, 485–492. 10.1161/circresaha.108.178384
67
SomlyoA. P.SomlyoA. V. (1994). Signal transduction and regulation in smooth muscle. Nature372, 231–236. 10.1038/372231a0
68
SomlyoA. P.SomlyoA. V. (2003). Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev.83, 1325–1358. 10.1152/physrev.00023.2003
69
SurksH. K.MendelsohnM. E. (2003). Dimerization of cGMP-dependent protein kinase 1alpha and the myosin-binding subunit of myosin phosphatase: role of leucine zipper domains. Cell. Signal.15, 937–944. 10.1016/s0898-6568(03)00057-3
70
SurksH. K.MochizukiN.KasaiY.GeorgescuS. P.TangK. M.ItoM.et al (1999). Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. Sci. (New York, NY)286, 1583–1587. 10.1126/science.286.5444.1583
71
SwärdK.DrejaK.SusnjarM.HellstrandP.HartshorneD. J.WalshM. P. (2000). Inhibition of Rho-associated kinase blocks agonist‐induced Ca2+ sensitization of myosin phosphorylation and force in Guinea-pig ileum. J. Physiol.522, 33–49. 10.1111/j.1469-7793.2000.0033m.x
72
Trinkle-MulcahyL.IchikawaK.HartshorneD. J.SiegmanM. J.ButlerT. M. (1995). Thiophosphorylation of the 130-kDa subunit is associated with a decreased activity of myosin light chain phosphatase in alpha-toxin-permeabilized smooth muscle. J. Biol. Chem.270, 18191–18194. 10.1074/jbc.270.31.18191
73
ValovičP.BehuliakM.VaněčkováI.ZichaJ. (2023). Impaired vascular β-adrenergic relaxation in spontaneously hypertensive rats: the differences between conduit and resistance arteries. Eur. J. Pharmacol.958, 176045. 10.1016/j.ejphar.2023.176045
74
VatnerS. F.ZhangJ.VyzasC.MishraK.GrahamR. M.VatnerD. E. (2021). Vascular stiffness in aging and disease. Front. Physiol.12, 762437. 10.3389/fphys.2021.762437
75
WalshM. P.Clment-ChomienneO.AndreaJ. E.AllenB. G.HorowitzA.MorganK. G. (1996). Protein kinase C mediation of Ca2+-independent contractions of vascular smooth muscle. Biochem. Cell Biol.74, 485–502. 10.1139/o96-053
76
WilsonD. P.SutherlandC.BormanM. A.DengJ. T.MacDonaldJ. A.WalshM. P. (2005). Integrin-linked kinase is responsible for Ca2+-independent myosin diphosphorylation and contraction of vascular smooth muscle. Biochem. J.392, 641–648. 10.1042/bj20051173
77
WoodsomeT. P.PolzinA.KitazawaK.EtoM.KitazawaT. (2006). Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J. Cell Sci.119, 1769–1780. 10.1242/jcs.02805
78
YapJ.ChenX.DelmotteP.SieckG. C. (2020). TNFα selectively activates the IRE1α/XBP1 endoplasmic reticulum stress pathway in human airway smooth muscle cells. Am. J. Physiol-lung C318, L483–L493. 10.1152/ajplung.00212.2019
79
YuS.McEnieryC. M. (2020). Central versus peripheral artery stiffening and cardiovascular risk. Arter. Thromb. Vasc. Biol.40, 1028–1033. 10.1161/atvbaha.120.313128
80
YuenS.OgutO.BrozovichF. V. (2011). MYPT1 protein isoforms are differentially phosphorylated by protein kinase G. J. Biol. Chem.286, 37274–37279. 10.1074/jbc.m111.282905
81
YuenS. L.OgutO.BrozovichF. V. (2009). Nonmuscle myosin is regulated during smooth muscle contraction. Am. J. Physiol-heart C297, H191–H199. 10.1152/ajpheart.00132.2009
82
YuenS. L.OgutO.BrozovichF. V. (2014). Differential phosphorylation of LZ+/LZ- MYPT1 isoforms regulates MLC phosphatase activity. Archives Biochem. biophysics562C, 37–42. 10.1016/j.abb.2014.08.011
83
ZhangH.FisherS. A. (2007). Conditioning effect of blood flow on resistance artery smooth muscle myosin phosphatase. Circ. Res.100, 730–737. 10.1161/01.res.0000260189.38975.35
84
ZhangJ.ZhaoX.VatnerD. E.McNultyT.BishopS.SunZ.et al (2018). Extracellular matrix disarray as a mechanism for greater abdominal versus thoracic aortic stiffness with aging in primates. Arter. Thromb. Vasc. Biol.36, 700–706. 10.1161/atvbaha.115.306563
85
ZhangW.GunstS. J. (2017). Non-muscle (NM) myosin heavy chain phosphorylation regulates the formation of NM myosin filaments, adhesome assembly and smooth muscle contraction. J. Physiology595, 4279–4300. 10.1113/jp273906
86
ZhengX.RehoJ. J.WirthB.FisherS. A. (2015). TRA2β controls Mypt1 exon 24 splicing in the developmental maturation of mouse mesenteric artery smooth muscle. AJP Cell Physiol.308, C289–C296. 10.1152/ajpcell.00304.2014
87
ZhongC.XuM.BoralS.SummerH.LichtenbergerF.-B.ErdoğanC.et al (2021). Age impairs soluble guanylyl cyclase function in mouse mesenteric arteries. Int. J. Mol. Sci.22, 11412. 10.3390/ijms222111412
Summary
Keywords
vascular reactivity, MYPT1, NM myosin, NO, endothelial independent and dependent vasodilatation
Citation
Han YS, Bandi R, Fogarty MJ, Sieck GC and Brozovich FV (2024) Aging related decreases in NM myosin expression and contractility in a resistance vessel. Front. Physiol. 15:1411420. doi: 10.3389/fphys.2024.1411420
Received
02 April 2024
Accepted
01 May 2024
Published
14 May 2024
Volume
15 - 2024
Edited by
Stephen Vatner, The State University of New Jersey, United States
Reviewed by
Steven S. An, The State University of New Jersey, United States
William F. Jackson, Michigan State University, United States
Updates
Copyright
© 2024 Han, Bandi, Fogarty, Sieck and Brozovich.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frank V. Brozovich, brozovich.frank@mayo.edu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.